Clinical value of antibodies to lysobisphosphatidic acid in patients with primary antiphospholipid sindrome
To assess the clinical value of anti-lysobisphosphatidic acid (anti-LBPA) antibodies in patients with primary antiphospholipid syndrome (APS), the sera of 140 primary APS patients were tested and compared with those of 70 control subjects affected with rheumatic systemic diseases (n. 24) or autoimmu...
Main Authors: | S. Giunco, S. Cuffaro, E. Salvan, A. Cavazzana, A. Bontadi, A. Ruffatti, S. Olivieri, L. Punzi |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2011-06-01
|
Series: | Reumatismo |
Online Access: | http://www.reumatismo.org/index.php/reuma/article/view/471 |
Similar Items
-
Confirmation of antiphospholipid antibody positivity: a year’s results in a cohort of 113 patients
by: A. Ruffatti, et al.
Published: (2011-06-01) -
In vitro effect of anti-β2 glycoprotein I antibodies on P-selectin expression, a marker of platelet activation
by: A. Hoxha, et al.
Published: (2012-03-01) -
Síndrome de anticuerpos antifosfolípidos Syndrome of antiphospholipid antibodies
by: Pedro Omar Pouymiró Pubillones, et al.
Published: (2012-03-01) -
Drug‐induced increase in lysobisphosphatidic acid reduces the cholesterol overload in Niemann–Pick type C cells and mice
by: Moreau, D, et al.
Published: (2019) -
Primary antiphospholipid antibodies syndrome
by: Carmen Garrido Arce, et al.
Published: (2009-01-01)